Search for: "Isom v. Isom" Results 101 - 120 of 136
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Nov 2010, 7:35 am by Karen E. Keller
In a case involving certain chemical analogs and optical isomers, Chief Judge Sleet construed the following terms: - "S-(+)-4-amino-3-(2-methylpropyl) butanoic acid as a single optical isomer" - "4-amino-3-(2-methylpropyl) butanoic acid" Pfizer, Inc. v. [read post]
10 Oct 2010, 9:36 pm by Patent Docs
Pfizer Inc. et al. v. [read post]
19 Sep 2010, 4:06 pm
My query is whether data exclusivity of 10 years will apply to new products or not like isomer dugs ex: arformoterol, armodafinil, dexlansoprazole etc… These drugs got three years exclusivity in US. [read post]
29 Aug 2010, 8:29 am
On August 27, 2010, the Court of Civil Appeals released their opinion in the Water Works Board of the City of Birmingham v. [read post]
20 May 2009, 5:18 am
BIO Policy Briefing raises the IP social media question (PatentlyBIOtech) Vietnam: Patentability of medical use claims in Vietnam (RelatIP)   Products Actonel (Risedronic) – US: CAFC affirms Procter & Gamble’s Actonel patent validity; nonobviousness of positional isomer: Procter & Gamble v Teva (Patent Docs) (Patently-O) (SmartBrief) (SmartBrief) (GenericsWeb) Alimta (Pemetrexed) – US: Eli Lilly and Princeton University sue… [read post]
18 May 2009, 7:00 am
  There was no clear and convincing evidence of overlap between the patents, so there was no double patenting.More detail of Procter & Gamble Co. v. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]